In Brief: FDA's Dental Products/Plaque Subcommittee
This article was originally published in The Tan Sheet
Executive Summary
FDA's Dental Products/Plaque Subcommittee: Will meet Oct. 29-30. The agenda is not yet public. At the committee's last meeting, cetylpyridinium chloride, a mouthwash ingredient, was voted Category I for safety and efficacy in treating plaque and gingivitis; Microdent was voted Category I for safety and Category III for efficacy; and the committee called for more information on the efficacy of active ingredients in Warner-Lambert's Listerine mouthwash ("The Tan Sheet" May 12, pp. 4-7)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning